Extrait

To assess whether patients with castration resistant prostate cancer survive without their cancer getting worse (progression free survival) for longer than standard treatment, when receiving triamcinolone whilst continuing GnRH analog treatment and following failure of hormone therapy. This will be assessed by measuring PSA levels.

Critère d'inclusion

• Castration Resistent Prostate cancer

Liens

• euctr
• ictrp